Feeding Your Demons contemplative practice for women's well‑being and self‑deconstruction

Effectiveness of a Contemplative Practice on Psychological Well-Being, Self-Deconstruction, Body Image, Body Acceptance, and Compassion in Women

Not applicable Interventional Hospital Miguel Servet · NCT06950905

This project will test whether the Feeding Your Demons contemplative practice helps adult women improve psychological well‑being, body image, compassion, and self‑deconstruction compared with an eight‑week mindfulness program.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment122 (estimated)
Ages30 Years to 60 Years
SexFemale
SponsorHospital Miguel Servet Academic / other
Locations2 sites (Zaragoza, Zaragoza and 1 other locations)
Trial IDNCT06950905 on ClinicalTrials.gov

What this trial studies

This is a randomized controlled trial enrolling 122 adult women who will be randomly assigned to an eight‑week online Feeding Your Demons (FYD) program or an active mindfulness meditation control. Participants are 30–60 years old, Spanish‑speaking, and have at least one month of prior meditation experience; assessments occur before and after the intervention and at six months. Primary outcomes include measures of psychological well‑being, body image and acceptance, mindfulness, compassion, and self‑deconstruction, analyzed with repeated measures statistics and effect sizes. A nested qualitative component will conduct interviews with a subgroup to explore participant experiences in depth.

Who should consider this trial

Good fit: Ideal candidates are women aged 30–60 who are Spanish nationals or residents of Spain for more than five years, fluent in Spanish, with at least one month of meditation practice (regular sessions >15 minutes) and no eating‑disorder or psychiatric diagnoses.

Not a fit: Individuals with a formal eating‑disorder diagnosis, other psychiatric disorders, substance use disorder, significant depressive symptoms (PHQ‑9 ≥10), or a history of neurological disease are excluded and thus unlikely to benefit within this study.

Why it matters

Potential benefit: If successful, FYD could offer an accessible online program to reduce body dissatisfaction and increase self‑compassion and overall well‑being in adult women.

How similar studies have performed: Mindfulness‑ and compassion‑based interventions have shown benefits for well‑being and body image, but the Feeding Your Demons method is a novel, secular adaptation with limited prior clinical evidence.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Sex assigned female at birth and self-identifies as a woman
* Aged between 30 and 60 years
* Spanish nationality, or residency in Spain for more than 5 years
* Fluent in Spanish
* At least one month of experience with meditation or mindfulness practices, with a regular practice of more than 15 minutes per session
* Provides informed consent

Exclusion Criteria:

* Indicators of eating disorders (ED) or mental health deterioration, determined by the following cut-off points: SCOFF ≥ 2 and PHQ-9 ≥ 10
* Formal diagnosis of an eating disorder or any psychiatric condition
* Substance use disorder
* History of neurological disease diagnosis
* Participant's decision to withdraw from the study at any point

Where this trial is running

Zaragoza, Zaragoza and 1 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Mental HealthSelf ConceptBody DissatisfactionCompassionSelf-PerceptionMindfulness MeditationMeditationPsychological Well-being
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.